#UK Medical Cannabis
#UK Medical Cannabis · page 2
- Companies
Curaleaf Launches UK’s First CE-Certified Liquid Medical Cannabis Inhaler
Curaleaf Laboratories has announced the launch of the UK’s first CE-certified liquid medical cannabis inhaler, aiming to address growing patient and clinical demand for a discreet and reliable inhalation method.
- Events
Cannabis Europa 2025 – Key Insights Day 2
Below, we’ve summarised the key insights from the vibrant and diverse discussions throughout Day 2 of Cannabis Europa 2025. If you’re keen to dive into the details, we’ll be exploring each session in more detail over the coming weeks.
- Press releases
Dalgety Signs Strategic Partnership with Curaleaf Laboratories
Dalgety, a UK-based EU-GMP certified medical cannabis cultivator, is pleased to announce a strategic partnership with Curaleaf Laboratories, a trusted name in cannabis medicine and pharmaceutical-quality cannabinoid innovation.
- Medical
UK Companies Warn Ban On Medical Cannabis Exports Will Damage Future Investment
AS Brains Bioceuticals unveiled a significant expansion of its UK production facilities, it has warned that any future investment is under threat unless the UK Government changes its medical cannabis export rules.
- Medical
Medical Cannabis Access Bill To Be Debated By UK Parliament Today
MOVES to boost medical cannabis access to UK patients are set to be discussed in parliament today.
- CBD Market
A Thriving Legal UK Cannabis Industry Has The Potential To Create 100,000 Jobs
AS supporters of a UK Cannabis Industry Council meet for the first time today new policy proposals show a thriving sector could create almost 100,000 new UK jobs.
- Pharmaceutical
Channel Island Firm Secures Britain’s First High-THC Commercial Cultivation Licence For Over 20 Years
CHANNEL islands company Northern Leaf has successfully secured a medical cannabis cultivation licence to produce medicines for the UK and European markets.
- Opinion
‘Failing’ Government Report Into Medicinal Cannabis Is A ‘Missed Opportunity’
The Advisory Council for the Misuse of Drugs’ recent report on cannabis medicines is a missed opportunity, says Pierre Van Weperen of The Grow Group AS a leading distributor of unlicensed CBMPs in the UK, Grow Pharma welcomes research commissioned by the government into this very exciting and rapidly growing area.
- Medical
Younger Generation Of Doctors ‘See Cannabis As A Medicine – Not A Drug’
Dr Sunil Arora talks to BusinessCann about his journey from cannabis sceptic to cannabis prescriber ONE of the issues Dr Sunil Arora currently faces is weaning his patients off their illicit supplies which some consume in cannabis cakes or chocolate sauces.
- Opinion
It’s Time To ‘Open Cannabis’ Prescriptions To NHS Patients
Alex Fraser, Patient Access Lead with Grow Pharma, on the recently-launched ‘Open Cannabis’ campaign THE truth is there are a huge number of patients with chronic pain and other symptoms who are unaware that cannabis medicines are a legal option for them.
- Medical
Grow Pharma Signs Partnership Deal With Australia’s Althea – Boosting UK Medical Cannabis Range by 20%
UK MEDICAL cannabis distributor Grow Pharma has boosted its patient product range by 20% after striking a new deal with Althea Group Holdings.
